The purpose of this training program is to prepare MD, MD/PhD, or PhD postdoctoral fellows for research careers in the multidisciplinary field of Transfusion Medicine. Since 1985, 35 individuals have participated in this Training Program at the University of Pennsylvania. With few exceptions, all trainees have pursued careers in academic medicine and have continued on in either clinical or basic research having obtained many federal and non-federal grants along the way. Of the 28 who have already completed training, 20 former trainees have become directors or associate directors of academic blood banks and transfusion medicine sections across the country. Because of the many interested, qualified applicants and our successful training record, the program was awarded this T32 training grant beginning in 1994. This has allowed us to provide support for 13 of the 35 individuals. The uniqueness of this program lies in the availability of a broad-based research environment coupled with a well-established clinical Transfusion Medicine training program. This represents one of few such Transfusion Medicine postdoctoral training programs in this country. Research trainees conduct independent research for at least 2 years in the laboratory of an experienced mentor. Mentors are selected among faculty with diverse interests including cell membrane structure/function (red cells, platelets), immunobiology of autoimmune and neoplastic disorders, hematopoiesis and stem cell biology, blood coagulation, virology, and genetic engineering. Opportunities to coordinate trainee research experience with our Transfusion Medicine/Hemostasis Clinical Trial Network is featured in this renewal along with significant emphasis in the area of translational research and cell engineering in which our institution has invested considerable resources. The mentors selected for this program include many senior scientists with extensive experience training postdoctoral fellows and with current, active, interlaboratory collaborations. In addition to investigative work, the Training Program comprises an integrated mix of educational components including didactics, journal clubs, seminars, venues for presentation of trainees'research, as well as a requirement that each trainee participate in one or more teaching opportunities. The program plan includes specific steps for minority recruitment and for the training of MD's with little research experience. Educational programs for trainees in bioethics, grant writing, laboratory safety, and laboratory management are also included. The program's Director and Oversight Committee strive to design an educational experience tailored for each individual trainee.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007775-20
Application #
8484415
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Welniak, Lisbeth A
Project Start
1993-07-01
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
20
Fiscal Year
2013
Total Cost
$72,760
Indirect Cost
$9,877
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Carnemolla, Ronald; Villa, Carlos H; Greineder, Colin F et al. (2017) Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury. FASEB J 31:761-770
Brenner, Jacob S; Bhamidipati, Kartik; Glassman, Patrick M et al. (2017) Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine 13:1495-1506
Villa, Carlos H; Cines, Douglas B; Siegel, Don L et al. (2017) Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond. Transfus Med Rev 31:26-35
Kiseleva, Raisa; Greineder, Colin F; Villa, Carlos H et al. (2017) Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. PLoS One 12:e0169537
Fesnak, Andrew; Lin, ChieYu; Siegel, Don L et al. (2016) CAR-T Cell Therapies From the Transfusion Medicine Perspective. Transfus Med Rev 30:139-45
Villa, Carlos H; Anselmo, Aaron C; Mitragotri, Samir et al. (2016) Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. Adv Drug Deliv Rev 106:88-103
Villa, Carlos H; Seghatchian, Jerard; Muzykantov, Vladimir (2016) Drug delivery by erythrocytes: ""Primum non nocere"". Transfus Apher Sci 55:275-280
Fesnak, Andrew D; June, Carl H; Levine, Bruce L (2016) Engineered T cells: the promise and challenges of cancer immunotherapy. Nat Rev Cancer 16:566-81
Ostertag, Eric M; Bdeir, Khalil; Kacir, Stephen et al. (2016) ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model. Transfusion 56:1775-85
Karimi, Mobin A; Bryson, Jerrod L; Richman, Lee P et al. (2015) NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT. Blood 125:3655-63

Showing the most recent 10 out of 45 publications